NEWLINK GENETICS CORP's ticker is NLNK and the CUSIP is 651511107. A total of 124 filers reported holding NEWLINK GENETICS CORP in Q4 2016. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $5,566,000 | -29.7% | 541,472 | +2.8% | 0.00% | 0.0% |
| Q3 2016 | $7,912,000 | +35.9% | 526,762 | +1.9% | 0.00% | 0.0% |
| Q2 2016 | $5,821,000 | -38.5% | 516,956 | -0.6% | 0.00% | -50.0% |
| Q1 2016 | $9,464,000 | -50.2% | 520,023 | -0.5% | 0.00% | -33.3% |
| Q4 2015 | $19,013,000 | +8.7% | 522,471 | +7.0% | 0.00% | 0.0% |
| Q3 2015 | $17,497,000 | -14.9% | 488,209 | +5.2% | 0.00% | 0.0% |
| Q2 2015 | $20,550,000 | -22.0% | 464,187 | -3.6% | 0.00% | -25.0% |
| Q1 2015 | $26,342,000 | +78.4% | 481,477 | +29.6% | 0.00% | +100.0% |
| Q4 2014 | $14,764,000 | +223.8% | 371,432 | +74.5% | 0.00% | +100.0% |
| Q3 2014 | $4,559,000 | -25.2% | 212,838 | -7.3% | 0.00% | 0.0% |
| Q2 2014 | $6,095,000 | -1.6% | 229,577 | +5.2% | 0.00% | 0.0% |
| Q1 2014 | $6,197,000 | +39.7% | 218,220 | +8.2% | 0.00% | 0.0% |
| Q4 2013 | $4,437,000 | +11.2% | 201,592 | -5.1% | 0.00% | 0.0% |
| Q3 2013 | $3,991,000 | -2.1% | 212,523 | +2.8% | 0.00% | 0.0% |
| Q2 2013 | $4,077,000 | – | 206,746 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 93,533 | $962,000 | 1.69% |
| WALL STREET ASSOCIATES | 108,900 | $1,119,000 | 0.74% |
| NORTHWEST WEALTH MANAGEMENT, LLC | 57,482 | $591,000 | 0.60% |
| Orbimed Advisors | 1,991,700 | $20,475,000 | 0.26% |
| TFS CAPITAL LLC | 92,041 | $946,000 | 0.25% |
| Intrinsic Edge Capital Management LLC | 40,000 | $411,000 | 0.18% |
| SECOR Capital Advisors, LP | 100,529 | $1,033,000 | 0.13% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 176,077 | $1,810,000 | 0.12% |
| Piermont Capital Management Inc. | 41,400 | $426,000 | 0.10% |
| Vident Investment Advisory, LLC | 67,209 | $691,000 | 0.08% |